The Neurologist: Clinical & Therapeutics Journal
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Mini Article   
  • Neurol Clin Therapeut J 2023, Vol 7(5): 160
  • DOI: 10.4172/nctj.1000160

Dementia Unraveled: Navigating the Landscape of Alzheimer's disease

Brigo Drouin*
Department of Neuroscience, Paris Descartes University, France
*Corresponding Author : Brigo Drouin, Department of Neuroscience, Paris Descartes University, France

Received Date: Sep 05, 2023 / Accepted Date: Sep 28, 2023 / Published Date: Sep 29, 2023

Abstract

Alzheimer’s disease, a formidable challenge in modern healthcare, remains a complex enigma affecting millions worldwide. This neurodegenerative disorder, marked by progressive cognitive decline and memory loss, presents a profound emotional and financial burden on individuals, families, and society. Although Alzheimer’s has been studied for over a century, much of its intricacies remain elusive. This article delves into the Alzheimer’s enigma, exploring the journey from early signs to diagnosis and highlighting the critical role of early intervention. The diagnosis of Alzheimer’s involves observing subtle cognitive changes that evolve into significant disruptions in daily life. Advanced neuroimaging and cognitive assessments aid in diagnosis, yet a definitive confirmation remains post-mortem. This diagnostic complexity underscores the urgency of raising awareness and advocating for increased support for patients and caregivers. While a cure for Alzheimer’s remains elusive, research efforts have surged, offering hope for better treatments. Drug development, genetic investigations, and technological advancements are paving the way for improved diagnostics and therapies. Early intervention has emerged as a vital focus, with medications, lifestyle changes, and cognitive stimulation offering avenues to slow cognitive decline. In navigating the landscape of Alzheimer’s disease, this article emphasizes the importance of empathy, support, and reducing stigma. By unraveling the mysteries of Alzheimer’s, we inch closer to a future where effective treatments alleviate the burdens faced by individuals and families affected by this challenging condition.

Citation: Drouin B (2023) Dementia Unraveled: Navigating the Landscape of Alzheimer’s disease. Neurol Clin Therapeut J 7: 160. Doi: 10.4172/nctj.1000160

Copyright: © 2023 Drouin B. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top